Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals : study protocol for a randomized controlled trial
Kaydedildi:
| Yazar: | |
|---|---|
| Yayın Tarihi: | 2016 |
| Diğer Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Article |
| Dil: | eng |
| Kaynak: | Repositório Institucional da UnB |
| Download full: | https://repositorio.unb.br/handle/10482/41717 https://doi.org/10.1186/s13063-016-1302-8 |
Özet: | Background: Resistant hypertension (RH) treatment requires an adequate and intense therapeutic approach. However, the results are not always satisfactory despite intensive treatment. Of the different pathophysiological mechanisms involved in the pathogenesis of RH, sympathetic overstimulation and therapies that block the sympathetic system have been widely studied. These approaches, however, are invasive and expensive. Another possible approach is by transcutaneous electrical nerve stimulation (TENS), a noninvasive method that modulates activity by using low-frequency transcutaneous electrical stimulation to inhibit primary afferent pathways. Thus, the current study will evaluate the effect of applying TENS in the cervicothoracic region of subjects with RH and will seek to develop a new low-cost and readily available therapy to treat this group of hypertensive individuals. Methods/design: This is a randomized, single blind (subject), parallel-assignment study controlled with a sham group and including participants aged 40 to 70 years with resistant hypertension. The trial has two arms: the treatment and control (sham group). The treatment group will be submitted to the stimulation procedure (TENS). The sham group will not be submitted to stimulation. The primary outcomes will be a reduction in the peripheral blood pressure and adverse events. The secondary outcomes will be a reduction the central blood pressure. The study will last 30 days. The sample size was calculated assuming an alpha error of 5 % to reject the null hypothesis with a statistical power of 80 %, thereby resulting in 28 participants per group (intervention versus sham). Discussion: In recent decades, RH has become very common and costly. Adequate control requires several drugs, and in many cases, treatment is not successful. Sympathetic nervous system inhibition by renal denervation and central inhibition have significant effects in reducing BP; however, these treatments are costly and invasive. Another type of sympathetic nervous system inhibition can also be noninvasively achieved by electric current. Therefore, the application of TENS may be a new therapeutic option for treating resistant hypertensive individuals. Trial Registration: Clinical Trials NCT02365974 |
Benzer Materyaller: Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals : study protocol for a randomized controlled trial
- Transcutaneous electrical nerve stimulation in speech therapy rehabilitation of voice and swallowing function in adults-a systematic review
- Eleitos da eletro-estimulação transcutânea ganglionar no sistema cardiovascular em cardiopatas
- New insights for statistical analysis of blood pressure response to resistance training in elderly hypertensive women
- The effect of quadriceps muscle length on maximum neuromuscular electrical stimulation evoked contraction, muscle architecture, and tendon-aponeurosis stiffness
- Access to and use of high blood pressure medications in Brazil
- Validação do teste de exercício de 4 segundos durante a simulação de propulsão em cadeira de rodas